Brazil Establishes Comprehensive Track-and-Trace System for Drugs

International Pharmaceutical Regulatory Monitor
A A
Drugmakers that market products in Brazil have two years to present Anvisa with a full report of traceability of at least three batches, according to a resolution published in the Dec. 11 Official Journal.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00